flutamide has been researched along with fosfestrol in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kato, Y; Kurita, M; Suzuki, K; Tamura, Y; Yamanaka, H | 1 |
Fukabori, Y; Ito, K; Kurokawa, K; Nakazato, H; Suzuki, K; Yamanaka, H | 1 |
Furuya, Y; Fuse, H; Nagakawa, O; Nozaki, T | 1 |
Igaki, H; Kaizu, T; Karasawa, K; Matsuda, T; Niibe, Y; Shinohara, M; Tanaka, Y | 1 |
1 review(s) available for flutamide and fosfestrol
Article | Year |
---|---|
Rotational 3D-conformal radiation therapy (conformation therapy) combined with hormone therapy for the treatment of stage B2/C prostate cancer in Japanese men.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Chlormadinone Acetate; Diethylstilbestrol; Disease-Free Survival; Flutamide; Follow-Up Studies; Gastrointestinal Diseases; Goserelin; Humans; Imaging, Three-Dimensional; Japan; Life Tables; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prostatic Neoplasms; Radiation Injuries; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Retrospective Studies; Rotation; Survival Analysis; Treatment Outcome; Urination Disorders | 2003 |
1 trial(s) available for flutamide and fosfestrol
Article | Year |
---|---|
[Suppressive effects of the antiandrogen flutamide on adrenal androgens in advanced prostate cancer patients].
Topics: Adrenocorticotropic Hormone; Aged; Androgens; Depression, Chemical; Diethylstilbestrol; Drug Therapy, Combination; Flutamide; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Middle Aged; Prostatic Neoplasms | 2001 |
2 other study(ies) available for flutamide and fosfestrol
Article | Year |
---|---|
[A case of prostate cancer treated with combined androgen-blockade].
Topics: Adenocarcinoma; Androgen Antagonists; Antineoplastic Agents; Diethylstilbestrol; Flutamide; Humans; Male; Middle Aged; Prostatic Neoplasms | 2000 |
Low serum testosterone level predicts worse response to endocrine therapy in Japanese patients with metastatic prostate cancer.
Topics: Aged; Aged, 80 and over; Anilides; Antineoplastic Agents, Hormonal; Bone Neoplasms; Chlormadinone Acetate; Diethylstilbestrol; Disease Progression; Flutamide; Gonadotropin-Releasing Hormone; Humans; Japan; Male; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Predictive Value of Tests; Prostate-Specific Antigen; Prostatic Neoplasms; Statistics, Nonparametric; Testosterone; Tosyl Compounds | 2002 |